Simon Hickling - Willow Biosciences Sr Devel
| WLLW Stock | CAD 0.09 0.01 6.25% |
Insider
Simon Hickling is Sr Devel of Willow Biosciences
| Address | 202, 1201-5th Street SW, Calgary, AB, Canada, T2R 0Y6 |
| Phone | 403 910 5140 |
| Web | https://www.willowbio.com |
Willow Biosciences Management Efficiency
The company has return on total asset (ROA) of (0.7479) % which means that it has lost $0.7479 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (2.122) %, meaning that it generated substantial loss on money invested by shareholders. Willow Biosciences' management efficiency ratios could be used to measure how well Willow Biosciences manages its routine affairs as well as how well it operates its assets and liabilities. As of the 2nd of December 2024, Return On Tangible Assets is likely to drop to -2.05. In addition to that, Return On Capital Employed is likely to grow to -2.58. At this time, Willow Biosciences' Asset Turnover is very stable compared to the past year.Similar Executives
| Found 4 records | INSIDER Age | ||
| Bernard BSc | Cardiol Therapeutics Class | N/A | |
| MBA MBA | Cardiol Therapeutics Class | N/A | |
| Trevor Burns | Cardiol Therapeutics Class | N/A | |
| CA CMA | Cardiol Therapeutics Class | N/A | |
Management Performance
| Return On Equity | -2.12 | ||||
| Return On Asset | -0.75 |
Willow Biosciences Leadership Team
Elected by the shareholders, the Willow Biosciences' board of directors comprises two types of representatives: Willow Biosciences inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Willow. The board's role is to monitor Willow Biosciences' management team and ensure that shareholders' interests are well served. Willow Biosciences' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Willow Biosciences' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Sanjib LLB, Corporate Secretary | ||
| Simon Hickling, Sr Devel | ||
| Peter SeuferWasserthal, CEO Pres | ||
| Chris Savile, Director President | ||
| Troy Talkkari, Vice Development | ||
| Travis Doupe, Chief Officer | ||
| Trish Choudhary, Senior Development |
Willow Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Willow Biosciences a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -2.12 | ||||
| Return On Asset | -0.75 | ||||
| Operating Margin | (1.41) % | ||||
| Current Valuation | 13.16 M | ||||
| Shares Outstanding | 144.2 M | ||||
| Shares Owned By Insiders | 24.30 % | ||||
| Number Of Shares Shorted | 120.38 K | ||||
| Price To Earning | 4.00 X | ||||
| Price To Book | 62.86 X | ||||
| Price To Sales | 6.66 X |
Pair Trading with Willow Biosciences
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Willow Biosciences position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Willow Biosciences will appreciate offsetting losses from the drop in the long position's value.Moving together with Willow Stock
Moving against Willow Stock
The ability to find closely correlated positions to Willow Biosciences could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Willow Biosciences when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Willow Biosciences - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Willow Biosciences to buy it.
The correlation of Willow Biosciences is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Willow Biosciences moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Willow Biosciences moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Willow Biosciences can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Other Information on Investing in Willow Stock
Willow Biosciences financial ratios help investors to determine whether Willow Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Willow with respect to the benefits of owning Willow Biosciences security.